These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1507 related articles for article (PubMed ID: 9445196)
1. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Brierley J; Tsang R; Panzarella T; Bana N Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234 [TBL] [Abstract][Full Text] [Related]
3. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926 [TBL] [Abstract][Full Text] [Related]
4. Management and outcome of recurrent well-differentiated thyroid carcinoma. Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer. Chen PV; Osborne R; Ahn E; Avitia S; Juillard G Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224 [TBL] [Abstract][Full Text] [Related]
8. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related]
10. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients]. Gemsenjäger E; Heitz PU; Martina B; Schweizer I Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916 [TBL] [Abstract][Full Text] [Related]
11. [Prospective therapy study in differentiated thyroid carcinoma]. Gemsenjäger E; Heitz P; Martina B Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342 [TBL] [Abstract][Full Text] [Related]
13. High recurrent rate of multicentric papillary thyroid carcinoma. Lin JD; Chao TC; Hsueh C; Kuo SF Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244 [TBL] [Abstract][Full Text] [Related]
14. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. Yildirim E J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848 [TBL] [Abstract][Full Text] [Related]
15. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
16. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605 [TBL] [Abstract][Full Text] [Related]
17. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244 [TBL] [Abstract][Full Text] [Related]
18. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534 [TBL] [Abstract][Full Text] [Related]
19. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Haq M; Harmer C Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Lang BH; Lo CY; Chan WF; Lam KY; Wan KY Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]